Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,242 | -23,328 | -4,811 | -12,391 | -21,699 |
| Depreciation Amortization | 2,453 | 1,666 | 1,036 | 499 | 2,245 |
| Accounts payable and accrued liabilities | 1,234 | 602 | 1,745 | 298 | N/A |
| Other Working Capital | 36,408 | 40,299 | 29,668 | 52,688 | 19,545 |
| Other Operating Activity | 3,067 | 1,163 | -1,095 | -122 | 510 |
| Operating Cash Flow | $-80 | $20,402 | $26,543 | $40,972 | $601 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,553 | -3,647 | -1,977 | -364 | -1,651 |
| Purchase Of Investment | -275,224 | -141,067 | -29,640 | -19,060 | N/A |
| Sale Of Investment | 25,373 | 14,873 | 9,857 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 10,149 |
| Investing Cash Flow | $-254,404 | $-129,841 | $-21,760 | $-19,424 | $8,498 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 219,117 | 220,238 | 177 | 47 | N/A |
| Common Stock Repurchased | -7 | -2 | -1 | -1 | N/A |
| Other Financing Activity | 119,914 | 119,914 | 119,554 | 0 | 126 |
| Financing Cash Flow | $339,024 | $340,150 | $119,730 | $46 | $126 |
| Beginning Cash Position | 34,986 | 34,986 | 34,986 | 34,986 | 25,761 |
| End Cash Position | 119,526 | 265,697 | 159,499 | 56,580 | 34,986 |
| Net Cash Flow | $84,540 | $230,711 | $124,513 | $21,594 | $9,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80 | 20,402 | 26,543 | 40,972 | 601 |
| Capital Expenditure | -4,553 | -3,647 | -1,977 | -364 | N/A |
| Free Cash Flow | -4,633 | 16,755 | 24,566 | 40,608 | 601 |